James Merson's most recent trade in Cidara Therapeutics Inc was a trade of 11,100 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | James Merson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 11,100 | 11,100 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | James Merson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 2,125 | 2,125 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | James Merson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 4,250 | 4,250 | - | - | Stock Option (right to buy) |